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1079-83 Clinical Results Using the St. Jude Medical "Symmetry" 
Aortic Connector System in 400 Coronary Artery 
Bypass Patients
Theodore C. Koutlas, David Maziarz, Anne Conquest, J. Mark Williams, Walter W. Scott, 
Jr., Alan P. Kypson, W. Randolph Chitwood, Jr., Brody School of Medicine at East 
Carolina University, Greenville, NC
Background:
The St. Jude Medical “Symmetry” aortic-saphenous vein graft connector system was
introduced in the U.S. in 2001 as a suture-less method of performing proximal aorto-
saphenous vein anastomoses during coronary bypass surgery.
Methods:
Over a 27-month period (6/2001 to 9/2003) over 650 aortic-saphenous vein connectors
were deployed in 400 coronary artery bypass graft (CABG) patients at our institution. The
mean patient age was 66 years (range 37-86), and 65% of patients were male. The
majority of patients were first-operation CABG, while 10% (41/400) were either re-do
CABG or combined valve-CABG procedures. Off-pump procedures were performed in
28% (99/359) of the first-time CABG procedures. Data for this study were gathered in a
prospective fashion with regard to connector usage, while outcomes data were derived
retrospectively from the cardiac surgery database.
Results:
Only 18 connectors required conversion to a hand-sewn anastomosis after deployment,
primarily because of excessive bleeding at the anastomotic site. While re-exploration for
bleeding was required in 2.7% (11/400) patients, bleeding was never attributed to the
proximal connector site. Neurologic complications (stroke or delirium) occurred in 1.7%
(7/400) of patients, and there were no post-operative myocardial infarctions. Post-opera-
tive (30-day) mortality was 2.2% (9/400) for this group of patients. To date we have docu-
mented only 3 graft failures attributed to the use of the proximal connector, with 2
occlusions and 1 ostial stenosis.
Summary:
Our substantial early experience with the “Symmetry” aortic-saphenous vein connector
has demonstrated that a precise and hemostatic aortic-proximal saphenous vein connec-
tion is created using the system. There has been no documented morbidity related to the
use of the connector in over 2 years of use. While long-term results with regard to graft
patency have yet to be determined, our short-term operative results using the “Symme-
try” connector appear to be no different than historic results for our program.
1079-84 Utility of Routine Functional Testing After Coronary 
Artery Bypass Graft Surgery: Results From the 
ROSETTA-CABG Study
Mark J Eisenberg, Karen Okrainec, Karen Wou, Hiep Nguyen, Robert Duerr, Dominique 
Fourchy, Michael Del Core, Ellis Lader, Thao Huynh, Louise Pilote, Jewish General 
Hospital, Montreal, PQ, Canada
Background: There is little consensus regarding the use of functional testing after coro-
nary artery bypass graft surgery (CABG).
Objectives: To examine the effects of routine post-CABG functional testing on the use of
follow-up cardiac procedures and clinical events.
Methods: The Routine versus Selective Exercise Treadmill Testing after Coronary Artery
Bypass Graft Surgery (ROSETTA-CABG) Registry is a prospective multicenter study
examining the use of functional testing after CABG. A total of 357 patients were enrolled
at 16 clinical centers in 6 countries. A functional test was defined as one of the following:
exercise treadmill testing, stress echocardiogram or stress nuclear perfusion imaging.
Results: During the 12 month follow-up, 95 patients undewent a routine functional testing
strategy (100% having functional testing for routine follow-up), while 249 patients under-
went a selective strategy (88% having no functional testing and 12% having functional
testing for a clinical indication). There was little difference in the rates of follow-up cardiac
procedures among the patients undergoing the routine and selective testing strategies
(cardiac catheterization 1.1% vs 1.2%, p=NS; percutaneous coronary intervention [PCI]
1.1% vs 0.4%, p=NS; repeat CABG surgery 0.0% vs 0.0%, p=NS). However, clinical
events were less common among patients who underwent routine functional testing
including unstable angina (0.0% vs 1.6%, p=0.048), death (2.1% vs 0.8%, p=NS), com-
posite clinical events (2.1% vs 2.4%, p=0.03) but not myocardial infarction (0.0% vs
0.0%, p=NS). After controlling for baseline clinical and procedural differences, routine
functional testing had a persistent independent association with a reduction in the com-
posite clinical event rate (odds ratio=0.18, 95% confidence interval: 0.04 – 0.85, p=0.03).
Conclusion: Routine functional testing after CABG is associated with a reduction in the
frequency of follow-up clinical events. This association may be attributable to the early
identification and treatment of patients at risk for follow-up events, or it may be due to
clinical differences between patients who are referred for routine and selective functional
testing.
1079-85 Adjunctive Treatment With a Stent-Based Ventricle to 
Coronary Artery Bypass (VSTENT™) in Patients With 
Multivessel Disease Undergoing Coronary Artery 
Bypass Surgery (ADVANTAGE)
Peter Boekstegers, Philip Raake, Rabea Hinkel, Gerhard Steinbeck, Sandra Eiffert, 
Bruno Reichart, Calin Vicol, Grosshadern University Hospital, Munich, Germany
Background: We here report on the Munich experience using a stent-based approach for
surgical ventricle to coronary artery bypass which provides systolic instead of diastolic
blood flow distal to a high grade coronary artery stenosis. In addition to providing flow to
the distal vessel, collateral development and arterial remodeling might be induced by
VSTENT™ implantation.
Methods: In 11 patients (age 60 ± 4 y) undergoing multivessel coronary artery bypass
surgery a ventricle to coronary artery bypass was established using a ePTFE-membrane
covered VSTENT™ between the left ventricle and an obtuse marginal branch (n=6), a
ramus intermedius (n=1) or a diagonal branch (n=4) distal to a high grade coronary
artery stenosis.
Results: Epicardial coronary flow (flow wire) measurements including determination of
adenosine induced flow reserve and dobutamine stress testing were performed before
and after VSTENT™ implantation. Flow wire measurements assessed before and 7 days
after VSTENT™ implantation revealed a change of coronary flow pattern from diastolic to
predominantly systolic flow (systolic/diastolic flow ratio: 0.3±0.1 to 1.6±0.3, p<0.01). Dur-
ing dobutamine stress testing no regional wall motion abnormalities were detected in the
area supplied by the VSTENT™ and none of the patients developed clinical or electro-
cardiographic signs of ischemia. 6 months angiographic follow up will be available at pre-
sentation. Conclusions: Surgical VSTENT™ implantation providing a ventricle to
coronary artery bypass was feasible and safe in the short term follow up and was associ-
ated with a significant change of coronary flow pattern from diastolic to predominantly
systolic flow distal to a high grade stenosis of the native vessel at rest and under stress
testing.
1079-86 The Introduction of Drug-Eluting Stents Causes a Shift 
From Coronary Artery Bypass Graft Towards 
Percutaneous Coronary Intervention: One-Year 
Outcome of a Single-Center Experience of 2,200 
Consecutive Procedures
Ron T. Van Domburg, Tommy K. Liu, Pedro A. Lemos, Johanna J. Takkenberg, Lex A. 
van Herwerden, Peter C. Smits, Angeliek Venema, Patrick W. Serruys, Ad J. Bogers, 
Erasmus Medical Center, Rotterdam, The Netherlands
Background: Sirolimus-eluting stents (SES) were introduced for routine use in Europe in
April 2002. To study the impact of this new treatment on the overall clinical management
of candidates for revascularization, we evaluated a series of unselected consecutive pro-
cedures during 6 months after the introduction of SES and during the 6 months before.
Methods: Patients who are referred to our institution for coronary revascularization are
routinely discussed by a team consisting of thoracic surgeons and interventional cardiol-
ogists, who conjointly select the optimal treatment. Since the introduction of SES on April
16, until October 15 2002, 798 consecutive patients were referred to PCI and 275
patients to CABG (SES-group). For comparison, we evaluated a pre-SES group com-
posed of all PCIs (n=806) and CABGs (n=314) performed over the same 6-months
period immediately prior to April 15th, 2002. The primary endpoint was major adverse
cardiac events (MACE) at one year. Results: Compared to the pre-SES era, patients
treated with SES had more anatomical complex procedures, such as more multivessel
dilatations (28% vs 24%;p=0.04), more bifurcation dilatations (18% vs 7%;p<0.0001) and
the use of more stents (1.9 vs 1.5;p=0.01). In the CABG population a shift was observed
towards more 3 vessel disease (3VD: pre-SES:64%, post-SES:77%;p=0.01). At one year
PCI patients treated with SES had a 25% reduction in MACE as compared with the pre-
SES stent group (14.4% vs 19.6%; p<0.01). Of the CABG patients only 5.0% had MACE
in both study phases. Conclusions: While the incidence of MACE in CABG patients
remained virtually the same, the introduction of SES and the 25% reduction of coronary
reinterventions certainly has an impact on clinical practice regarding the choice betrween
CABG or PCI. Despite more multivessel disease patients and the treatment of more
bifurcation lesions, the incidence of MACE after PCI decreased. PCI with SES is closing
in on CABG.
1079-87 Predictors of 10-Year Patency of Saphenous Vein and 
Left Internal Mammary Artery Grafts After Coronary 
Artery Bypass Surgery: Results From a Department of 
Veterans Affairs Cooperative Study
Steven Goldman, Karen Zadina, Thomas Moritz, Theron Ovitt, Gulshan Sethi, Jack G. 
Copeland, Lizy Thottapurathu, Barbara Krasnicka, Nancy Ellis, Robert Anderson, William 
Henderson, Southern Arizona Veterans Affairs Health Care System, Tucson, AZ, 
Department of Veterans Affairs Hospital, Hines, IL
Background: The long-term success of coronary artery bypass grafting (CABG) is
dependent upon the patency of the grafts that are placed at the time of surgery. This VA
Cooperative Studies Trial prospectively defined long-term (ten-year) saphenous vein
graft (SVG) patency in 1,076 patients and left internal mammary artery (IMA) patency in
471 patients undergoing CABG.
Table of Contents
Methods: Patients underwent serial cardiac catheterizations at 1 week, 1 year, 3 years, 6
years and 10 years after CABG.
Results: Patency at ten years was 59% for SVGs and 84% for IMA grafts. If a SVG or
IMA graft was patent at one week, that graft had a 67% and 87% chance, respectively, of
being patent at ten years. At ten years the SVG patency to the LAD (66%) was better
(P<0.001) than to the right coronary artery (54%), or circumflex (57%). In vessels > 2.0
mm in diameter the ten-year SVG patency was 88% versus 53% in vessels < 2.0 mm
(P<0.001). The other significant positive ten-year predictors of graft patency were age of
patient, presence of angina, dyspnea on exertion, vein harvesting technique, serum cho-
lesterol, and use of topical flush to prepare the vein. Type of preservation solution, Cana-
dian Functional Class, cardioplegic solution given via graft, and lowest body temperature
are mildly predictive of 10-year graft patency, p=0.05–0.10.
Conclusions: Based on prospective angiographic follow-up after CABG, the long-term
patency for SVGs is better and the long-term patency for IMA grafts is worse than
expected. The best long-term predictors of graft patency are: 1) grafting into the LAD and
2) grafting into a vessel that is >2.0 mm in diameter.
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1079-88 Revascularization Alone for Functional Mitral 
Regurgitation: A Propensity Case-Match Analysis of the 
Off Pump Coronary Artery Bypass Approach
Paul C. Saunders, Eugene A. Grossi, Charles F. Schwartz, Robert M. Applebaum, Greg 
H. Ribakove, Alfred T. Culliford, Aubrey C. Galloway, Stephen B. Colvin, New York 
University Medical Center, New York, NY
Objective: Patients with mild or moderate functional mitral regurgitation (MR) are at
increased risk for poor outcomes after coronary revascularization. When these patients
receive coronary revascularization alone, it is unclear if an off-pump approach (OPCAB)
affects outcomes.
Methods: 1078 patients with functional mitral regurgitation underwent CABG alone
between 1996 and 2002; 222 performed off-pump and 856 using cardiopulmonary
bypass (CPB-CABG). Using intraoperative transesophageal echocardiography (TEE),
MR was classified as mild (n=848), moderate (n=223), and severe (n=7). Propensity
analysis was used to construct matched cohorts of patients with mild and moderate MR
undergoing OPCAB(n=127) and CPB-CABG(n=127). Matching variables included age,
sex, degree of MR, ejection fraction, number of grafts performed, urgency of operation,
previous cardiac surgery, and co-morbidities such as renal disease, diabetes, atheroma-
tous aortic disease, peripheral vascular disease, COPD, history of stroke and previous
MI.
Results: Hospital mortality (6.3% vs. 5.5%, p=0.79) and mid-term(3yr.) survival (90.0%
vs. 94.9%, p=0.33) were similar between the CPB-CABG and OPCAB groups, respec-
tively. By multivariable analysis, factors associated with increased hospital mortality were
renal disease (Odds Ratio(OR)=8.4, p=0.001), reoperation (OR=5.6, p=0.08), and worse
degree of MR (OR=5.2, p=0.01). Mid-term survival was adversely affected by renal dis-
ease (OR=4.0, p=0.008), worse degree of MR (OR=2.5, p=0.07, and history of stroke or
cerebrovascular disease (OR=2.6, p=0.07).
Conclusions: Worsening insufficiency was associated with poorer outcomes in patients
with functional MR undergoing coronary revascularization alone, suggesting that they
might benefit from mitral valve intervention. Choice of technique (OPCAB vs. CPB-
CABG) was not a significant factor in hospital or mid-term mortality.
1079-101 Therapeutic Strategies and Outcomes in Patients With 
Previous Coronary Artery Bypass Graft Following a 
New Acute Coronary Syndrome: Insights From the 
GRACE Experience
Viviana Brito, Ricardo Perez de la Hoz, Edgado Sampó, Ernesto Duronto, Omar H. 
Dabbous, Neelam Gowda, Enrique P. Gurfinkel, The GRACE Investigators, Hospital San 
Martin, Buenos Aires, Argentina, ICYCC Fundación Favaloro, Buenos Aires, Argentina
Background Prior antecedents of coronary artery bypass graft (CABG) surgery are a
clinical feature of risk in patients with an acute coronary event.
Aim To compare outcomes in acute coronary syndrome (ACS) patients with a history of
CABG who were treated conservatively or invasively.
Methods and Results From a total of 30,588 patients included in this prospective analy-
sis of GRACE patients, 3794 had a history of CABG. In-hospital and 6-month follow-up
data were available from 3006 and 1638 patients, respectively. During the first 48 h, 405
patients underwent invasive treatment and 2601 conservative treatment. Antiplatelets,
antithrombins and glycoprotein (GP) IIb/IIIa inhibitors were more frequently used in the
invasive than the conservative group (aspirin 95 vs 89%; thienopyridine 88 vs 23%,
LMWH 36 vs 46%, GPIIb/IIIa 70 vs 9%; all P<0.001). Multivariate analysis was per-
formed to adjust for differences in baseline characteristics and potential confounders.
Major bleeding and stroke were more frequent in the invasive group. No difference in car-
diovascular death was observed between groups at 6-month follow-up. Using the
GRACE risk model, an initial conservative approach in patients with prior CAGB was not
related to a higher risk of in-hospital death/major bleeding.
Conclusion In spite of the imbalance in characteristics, we found no clear beneficial
trend in favor of an invasive approach and an increase in the risk of major bleeding or
stroke with this approach.
1079-102 Correlation Between Norepinephrine and Epinephrine 
Myocardial Spillover and Tumor Necrosis Factor-Alpha 
in Conventional Versus Off-Pump Coronary Artery 
Bypass Surgery
Francesco Donatelli, Michele Triggiani, Giovanni Marchetto, Andrea Moneta, Marco 
Pocar, Davide Passolunghi, Gianni Bolla, Alessio Assaghi, Barbara Sala, Orietta Borghi, 
Pino Fundarò, Pier Luigi Meroni, Luisa Gregorini, University of Milano, Milano, Italy
Background: Complete revascularization obtained by coronary artery bypass surgery
does not prevent long term left ventricular remodeling and heart failure development.
Periprocedural events linked to different surgical techniques, such as cardiopulmonary
bypass with cardioplegic arrest (CABG) versus off-pump procedures may trigger an irre-
versible microvascular dysfunction or myocytes necrosis and apoptosis.
Methods: To test this hypothesis we measured norepinephrine and epinephrine coronary
sinus and aortic spillover before and after surgery, simultaneously with Tumor Necrosis
Factor-alpha (TNF-alpha) measurements in 30 patients randomized to CABG (n=15), or
off-pump (n=15) coronary surgery. Plasma catecholamines were assessed by high per-
formance liquid chromatography and TNF-alpha by ELISA.
Results: Norepinephrine and epinephrine spillover was similar in the two groups before
surgery, being 1.38±0.62 and 1.08±0.45, respectively. After surgery norepinephrine spill-
over was 1.43±0.56, 0.72±0.49 in CABG and off-pump, respectively (P<0.05 CABG ver-
sus off-pump, means ±SD ). Epinephrine spillover was 1.27±0.16 and 0.65±0.15
respectively (P<0.05, CABG versus off-pump). TNF-alpha significantly increased only in
CABG patients being 22.17±6.79 and 35.4±5.98, pg/mL, before and after surgery
(P<0.05), respectively. After surgery norepinephrine spillover correlated with TNF-alpha
levels (P=0.01, R=0.553).
Conclusions: Patients undergoing off-pump interventions showed significantly lower cate-
cholamines spillover as compared to CABG, suggesting that the off-pump technique may
result less invasive, not only for a lower local and whole body inflammatory response but
also for a lower sympathetic drive. For the first time in humans we have detected an
increase in epinephrine-spillover after cardiac surgery. Further studies are necessary to
evaluate if the short-term advantages observed after off-pump coronary surgery translate
into a long-term attenuation of left ventricular remodeling and in the prevention of heart
failure progression.
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815-2 Long-Term Outcome of Patients With Cardiogenic 
Shock Complicating Acute Myocardial Infarction
David R. Holmes, Jr., David Hasdai, Jennifer White, Peter B. Berger, Mayo Clinic, 
Rochester, MN
INTRODUCTION: Although the early outcome of cardiogenic shock (CS) complicating
acute myocardial infarction (MI) has been well documented, the longer term outcome is
less well understood.
METHODS: The GUSTO I study enrolled patients with AMI from 1989 to 1993 and
included 1891 United States patients with CS. Vital status 9 years after study entry is
available in 1797 of whom 859 (47%) survived the first 30 days. These 859 patients form
the basis of this report.
RESULTS: Nine years after study entry, 53% of patients remained alive. Table 1 com-
pares the baseline characteristics of 30-day survivors who did and did not survive 9
years.
/
Using Cox regression methods for multivariable analysis, the following factors were sig-
nificantly associated with long-term mortality, age > 55, prior MI, diabetes, current
smoker, index revascularization all p <.001.
CONCLUSIONS: Although early mortality from cardiogenic shock remains high, those
Table 1: Crude odds ratios using the GRACE risk model (in-hospital events and 
6-month follow-up)
Variables (invasive treatment) Odds ratio 95% CI P value
Crude
Major bleeding 1.689 1.009–2.829 0.046
In-hospital death 1.036 0.614–1.748 0.895
Ischemic event 0.993 0.787–1.253 0.951
Six-month follow-up 0.865 0.646–1.159 0.332
Adjusted
Ischemic symptoms 1.026 0.801–1.312 0.841
In-hospital death 1.166 0.609–2.231 0.643
Combined endpoints 1.057 0.835–1.339 0.644
Major bleeding 1.499 0.828–2.714 0.181
Six-month follow-up 1.002 0.732–1.371 0.992
N Alive
457
Dead
402
P
Male 66.5% 65.7% .793
Age (yrs) 60.6 +/- 10.56 66.5 +/- 11.02 <.001
Diabetes 9.9% 20.6% <.001
Prior MI 10.8% 26.8% <.001
Anterior MI 37.7% 50.3% <.001
Inferior MI 60.1% 47.8% <.001
Revasc within 30 days
PTCA
CABG
PTCA or CABG
42.7%
21.9%
58.3%
28.9%
21.1%
46.3%
<.001
.763
<.001
